Correlation Between Vaccinex and Opus Genetics,

Can any of the company-specific risk be diversified away by investing in both Vaccinex and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaccinex and Opus Genetics,, you can compare the effects of market volatilities on Vaccinex and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Opus Genetics,.

Diversification Opportunities for Vaccinex and Opus Genetics,

-0.21

Correlation Coefficient

Vaccinex  Opus Genetics,

Very good diversification

The 3 months correlation between Vaccinex and Opus is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Vaccinex i.e., Vaccinex and Opus Genetics, go up and down completely randomly.

Pair Corralation between Vaccinex and Opus Genetics,

Given the investment horizon of 90 days Vaccinex is expected to under-perform the Opus Genetics,. In addition to that, Vaccinex is 2.47 times more volatile than Opus Genetics,. It trades about -0.29 of its total potential returns per unit of risk. Opus Genetics, is currently generating about 0.07 per unit of volatility. If you would invest  120.00  in Opus Genetics, on October 5, 2024 and sell it today you would earn a total of  6.00  from holding Opus Genetics, or generate 5.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.0%
Values	Daily Returns

Vaccinex  vs.  Opus Genetics,

Vaccinex

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Opus Genetics,

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Opus Genetics, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Opus Genetics, may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Vaccinex and Opus Genetics,

The main advantage of trading using opposite Vaccinex and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.

The idea behind Vaccinex and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.